- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05702541
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses
February 27, 2024 updated by: Alcon Research
The purpose of this clinical trial is to assess the clinical performance of LID223194 Multifocal (MF) contact lenses and commercially available Air Optix plus HydraGlyde (AOHG) MF contact lenses.
Eligible subjects will wear each study lens type in a cross-over fashion as randomized for approximately 2 days.
Study Overview
Status
Completed
Conditions
Detailed Description
Subjects will be expected to attend 3 scheduled visits for an individual duration of participation of up to 10 days.
Study Type
Interventional
Enrollment (Actual)
16
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Georgia
-
Johns Creek, Georgia, United States, 30097
- Johns Creek Research Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Key Inclusion Criteria:
- Able to understand and sign an consent form (ICF) that has been approved by an Institutional Review Board (IRB);
- Willing to stop wearing habitual contact lenses for the duration of study participation;
- Currently wearing multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;
- Other protocol-defined inclusion criteria may apply.
Key Exclusion Criteria:
- Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator;
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator;
- History of refractive surgery, or plan to have refractive surgery during the study;
- Current or history of dry eye in either eye that would preclude contact lens wear, in the opinion of the investigator;
- Monovision contact lens wear;
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: LID223194 MF, then AOHG MF
Lehfilcon A multifocal contact lenses worn first, followed by lotrafilcon B multifocal contact lenses, as randomized.
Each product will be worn in both eyes for 2 days in a daily wear modality.
CLEAR CARE will be used for daily cleaning and disinfection.
|
Silicone hydrogel multifocal contact lenses
Other Names:
Silicone hydrogel multifocal contact lenses
Other Names:
Commercially available cleaning and disinfection system for silicone hydrogel contact lenses
Other Names:
|
Other: AOHG MF, then LID223194 MF
Lotrafilcon B multifocal contact lenses worn first, followed by lehfilcon A multifocal contact lenses, as randomized.
Each product will be worn in both eyes for 2 days in a daily wear modality.
CLEAR CARE will be used for daily cleaning and disinfection.
|
Silicone hydrogel multifocal contact lenses
Other Names:
Silicone hydrogel multifocal contact lenses
Other Names:
Commercially available cleaning and disinfection system for silicone hydrogel contact lenses
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)
Time Frame: Day 2 of each study lens type worn during the corresponding crossover period
|
VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR).
A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity.
No hypothesis testing was pre-specified for this endpoint.
|
Day 2 of each study lens type worn during the corresponding crossover period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Clinical Trial Lead, Vision Care, Alcon Research, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 24, 2023
Primary Completion (Actual)
February 21, 2023
Study Completion (Actual)
February 21, 2023
Study Registration Dates
First Submitted
January 4, 2023
First Submitted That Met QC Criteria
January 19, 2023
First Posted (Actual)
January 27, 2023
Study Record Updates
Last Update Posted (Actual)
March 26, 2024
Last Update Submitted That Met QC Criteria
February 27, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLN705-M102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
Lee, Steven, M.D.CompletedMyopia, | Hyperopia, | Astigmatism, | Presbyopia, | Eye Strain,
-
Allotex, Inc.RecruitingPresbyopiaCzechia, Ireland, Turkey, United Kingdom
-
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.LENZ Therapeutics, IncRecruiting
-
Coopervision, Inc.Centre for Ocular Research & Education, CanadaRecruitingPresbyopiaUnited States, Canada
-
Optall VisionRecruiting
-
Allotex, Inc.TerminatedPresbyopiaBelgium, Ireland, United Kingdom
-
Coopervision, Inc.CORECompletedPresbyopiaUnited States, Canada
Clinical Trials on Lehfilcon A multifocal contact lenses
-
Alcon ResearchCompleted
-
University of Alabama at BirminghamAlcon ResearchCompleted
-
Alcon, a Novartis CompanyCompletedRefractive Error
-
Southern College of OptometryAlcon ResearchRecruitingRefractive Errors | Astigmatism | Contact Lens ComplicationUnited States
-
Alcon ResearchCompletedRefractive Error | Presbyopia | Hyperopia
-
Alcon, a Novartis CompanyCompletedRefractive ErrorUnited States
-
Southern College of OptometryAlcon ResearchActive, not recruitingRefractive Errors | Astigmatism | Contact Lens ComplicationUnited States
-
Alcon ResearchCompletedRefractive AmetropiaUnited States
-
Alcon ResearchCompletedRefractive Error | PresbyopiaJapan
-
Alcon ResearchCompletedRefractive Errors | PresbyopiaUnited States, Canada, United Kingdom